Watch Ticker

XORTX Therapeutics Inc. Common Stock

Go to XORTX Therapeutics Inc. Common Stock Website

$0.77

0.03 (3.49%)
Live
Previous Close

$0.744

Day Range

$0.7352 - $0.78

Previous Day Range

$0.7261 - $0.773799

Market Cap

$3.7 million USD

Day Vol.

54104

Previous Day Vol.

27632

Currency

USD

Primary Exchange

Nasdaq

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid met...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

XORTX Therapeutics closed a non-brokered private placement of 1,267,123 units at $0.73 per unit, raising $925,000. The proceeds will be used for gout programs, corporate purposes, and working capital.

Related tickers: XRTX.

Read Full Article

XORTX Therapeutics plans to raise up to $925,000 through a non-brokered private placement of common share units, with proceeds to be used for advancing gout and kidney disease programs and general corporate purposes.

Related tickers: XRTX.

Read Full Article
Trending Tickers

Please sign in to view